comparing the effects of 5% albumin and 6% hydroxyethyl starch 130/0.4 (voluven) on renal function as priming solutions for cardiopulmonary bypass: a randomized double blind clinical trial

conclusions administration of albumin compared to hes in patients with a normal renal function results in a lower drop of gfr and platelet count, less bleeding and lower rise of serum creatinine. background the ideal strategy to prime the cardiopulmonary bypass (cpb) circuit in adult cardiac surgery is still a matter of debate. objectives in this retrospective study, we examined albumin solution and hydroxyethyl starch (hes) for priming the cpb circuit and evaluated the differences in kidney function and bleeding and coagulation status in the two groups of patients. patients and methods sixty consecutive patients undergoing elective coronary artery bypass grafting were studied. patients were excluded due to emergency surgery, history of cardiac surgery, history of receiving medication with antiplatelet agents except asa 80 (mg/day) within the previous five days, preoperative coagulation disorder, left ventricular ejection fraction less than 50%, preoperative renal dysfunction (serum creatinine > 1.4 mg/dl), preoperative hepatic dysfunction (serum aspartate/alanine amino transferase > 60 u/l), preoperative electrolyte imbalance, known hypersensitivity to hes and chronic diuretic therapy. the patients were divided randomly into two groups of hes (n = 30) and albumin (n = 30). hemodynamic parameters, serum creatinine concentrations and glomerular filtration rate, pt, ptt and inr were measured. early bleeding was measured according to the first 24-hour drainage from the tube. hemodynamics and all laboratory measurements were performed after induction of anesthesia and at the morning of the first, second and third postoperative days in the icu. results gfr differences were statistically lower in albumin group in comparison with group b at 24, 48 and 72 hours postoperation. platelet count difference and postoperative bleeding were significantly lower in albumin group.